Results

Total Results: 1,189 records

Showing results for "diabetes".
Users also searched for: diabetes

341. Transparency of Reporting Requirements | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/transparency-reporting/overview
     August 23, 2016 - Transparency of Reporting Requirements Series Overview August 23, 2016 Bias in reporting results of scientific studies has been a significant problem in basic and clinical science. The lack of publication of results of trials can lead to unnecessary duplication . Results of studies reported in the peer…

342. Schedule of Visits and Use of Telemedicine for Routine Antenatal Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/routine-antenatal-care.pdf
     January 01, 2020 - and second trimester ultrasounds (for dating and viability and to evaluate anatomy, respectively), a diabetes … Allow studies of pregnant individuals at increased risk of poor outcomes (e.g., with gestational diabetes … Exclude: • Exclusions listed for KQ 1 • Telemedicine monitoring specifically for gestational diabetes … * Pregnancy complications: maternal mortality, antenatal pregnancy complications (gestational diabetes … ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus.

343. Schedule of Visits and Use of Telemedicine for Routine Antenatal Care: A Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
     January 01, 2020 - and second trimester ultrasounds (for dating and viability and to evaluate anatomy, respectively), a diabetes … Allow studies of pregnant individuals at increased risk of poor outcomes (e.g., with gestational diabetes … Exclude: • Exclusions listed for KQ 1 • Telemedicine monitoring specifically for gestational diabetes … * Pregnancy complications: maternal mortality, antenatal pregnancy complications (gestational diabetes … ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus.

344. Disposition of Comments for Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
     April 22, 2013 - about the efficacy of combined behavioral and pharmacological interventions for weight loss in SMI, diabetes … the contrary, there is a growing literature indicating that individuals with SMI and e.g., Type 2 diabetes … exhibit as good as or better adherence to hypoglycemic medications than diabetes patients without … The ADA/APA guidelines (Diabetes Care 2004;27:596) do make recommendations regarding some of the specific … What is unique about SMI that precludes evidence-based programs such as the Diabetes Prevention Program

345. Omega 3 Fatty Acids and Cardiovascular Disease - Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol
     April 02, 2015 - potential confounders or interacting factors—such as plasma lipids, body mass index, blood pressure, diabetes … , kidney disease, other nutrients or supplements, and drugs (e.g., statins, aspirin, diabetes drugs, … What adverse events are reported specifically among people with CVD or diabetes (in studies of CVD outcomes … * Specifically, cardiovascular medications, statins, antihypertensives, diabetes medications, hormone … = cerebrovascular accident (stroke), CVD = cardiovascular disease, DHA = docosahexaenoic acid, DM = diabetes

346. Fatty-Acids-Cardiovascular-Disease Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
     April 02, 2015 - , kidney disease, other nutrients or supplements, and drugs (e.g., statins, aspirin, diabetes drugs, … • What adverse events are reported specifically among people with CVD or diabetes (in studies of CVD … * Specifically, cardiovascular medications, statins, antihypertensives, diabetes medications, hormone … cerebrovascular accident (stroke), CVD = cardiovascular disease, DHA = docosahexaenoic acid, DM = diabetes … Options for Risk type: DM (diabetes), HTN (hypertension), CKD (chronic kidney disease), Dyslipidemia.

347. Antenatal Care | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/antenatal-care
     April 07, 2020 - been integrated into antenatal care (such as prenatal genetic screening, screening for gestational diabetes

348. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-protocol.pdf
     April 08, 2024 - Reported risks to the pregnant person include gestational diabetes, hypertension, cesarean section, … Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in … Fetal overnutrition in polynesian pregnancies and in gestational diabetes may lead to dysregulation … Diabetes Care. 2002 Sep;25(9):1539-44. doi: 10.2337/diacare.25.9.1539. PMID: 12196424. 26. … Research Protocol: The Effect of Dietary Digestible Carbohydrate Intake on Risk of Type 2 Diabetes,

349. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
     October 01, 2018 - This tool was based on a previously developed and tested decision aid for diabetes.11 The structure, … design, and themes of the diabetes cards were modified to fit the needs of patients with anxiety and … The letter referred users to a video showing a demonstration of how the diabetes decision aid was used … We noted that creating the encounter decision aid (which was a prototype based on an existing diabetes … The diabetes mellitus medication choice decision aid: a randomized trial.

350. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - update, we additionally considered the outcomes of non-HDL-c and triglycerides for the subgroup with diabetes … have revised and included non-HDL-c and TG synthesis for the relevant subgroup of participants with diabetes … Non-HDL-c and TG are now investigated in the relevant subgroup for this review – i.e. those with Diabetes … and TG outcome measures have now been considered for the relevant subgroup population of those with diabetes … and TG outcome measures have now been considered for the relevant subgroup population of those with diabetes

351. Lower Limb Prosthesis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prosthesis/research-protocol
     April 03, 2017 - are living with limb loss, a number expected to double by 2050 mostly due to the rising prevalence of diabetes … Current level of function Etiology of amputation Time since amputation Comorbidities (e.g., diabetes … "Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence

352. SEAD Submission Form for The Effect of Dietary Digestible Carbohydrate Intake on Risk of Type 2 Diabetes, Growth, Size, and Body Composition | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/form/effect-dietary-digestible

353. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - It would be akin to talking about ‘chronic diabetes’. … Gout is a "chronic" condition from the time of onset, similar to diabetes or hypertension. … (the terminology being used here is akin to talking about ‘chronic diabetes’ – one would not wait until … the complications of diabetes before controlling blood glucose). … However, the evidence about lower levels altering the risk benefit ratio for diabetes and hypertension

354. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Diabetes mellitus 8. Functional limitations and disability 9. … Association (ADA) 1, 11 Annual meeting presenting diabetes research X X X X X X X 8 American … (EASD) 1, 11 Annual meeting presenting diabetes research X X X X X X X 28 European Association … Federation’s (ISF) World Diabetes Congress 1, 11 Annual meeting presenting diabetes research … & Metabolism 1, 11 Annual meeting presenting diabetes research X X X X X X X 67 World Stroke

355. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Diabetes mellitus 8. Functional limitations and disability 9. … Association (ADA) 1, 11 Annual meeting presenting diabetes research X X X X X X X 8 American … (EASD) 1, 11 Annual meeting presenting diabetes research X X X X X X X 28 European Association … Federation’s (ISF) World Diabetes Congress 1, 11 Annual meeting presenting diabetes research … & Metabolism 1, 11 Annual meeting presenting diabetes research X X X X X X X 67 World Stroke

356. Stem-Cell-Children Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
     February 01, 2012 - Immunosuppressants, targeted biologic therapies and/or low- dose chemotherapy NM Autoimmune type 1 diabetes … With the exception of newly diagnosed type I juvenile diabetes, children in the studies reviewed had … conventional therapy or disease natural history in patients with newly diagnosed type 1 juvenile diabetes … achieved in some cases with single autologous HSCT for patients with newly diagnosed type I juvenile diabetes … In contrast, type I autoimmune juvenile diabetes can be managed long term satisfactorily, at relatively

357. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
     November 01, 2010 - autologous; BMF: bone marrow failure; CML: chronic myelogenous leukemia; CR: complete remission; DM: diabetes … allo Immunosuppressants, targeted biologic therapies and low-dose chemotherapy Autoimmune type 1 diabetes … Additional searching was done to obtain information on comparators in the following diseases: Diabetes … immunosuppressive OR "immune modulation" OR "immune suppression" 10:20:45 449395 #10 Search "Diabetes … Mellitus, Type 1"[Mesh] OR ("type 1" AND (diabetes OR diabetic OR DM)) OR "juvenile diabetes" 10:

358. Cervical Ripening in the Outpatient Setting | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cervical-ripening/protocol
     January 16, 2020 - child benefit when the health of a pregnant woman or fetus is at risk (e.g. maternal hypertension or diabetes … undergoing CR in the outpatient setting Important maternal subgroups: parity, maternal age, GBS status, diabetes … undergoing CR in the outpatient setting Important maternal subgroups: parity, maternal age, GBS status, diabetes … undergoing CR in the outpatient setting Important maternal subgroups: parity, maternal age, GBS status, diabetes … undergoing CR with a prostaglandin Important maternal subgroups: parity, maternal age, GBS status, diabetes

359. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/evidence-based-treatment-for-pressure-ulcers-by-stage
     September 22, 2010 - (check all that apply) EHC Priority Conditions (updated in 2008) Diabetes mellitus Functional

360. Symposium on Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research - Part III | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/patient-outcomes-symposium/executive
     May 03, 2012 - Effectiveness of More or Less Aggressive Treatment Intensification Strategies in Adults with Type 2 Diabetes